Explore comprehensive CDMO, CMO and CRO services offered by Biocon Biologics, supporting end-to-end Anlaytical Testing and Drug Development. Biocon Biologics enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: India, Malaysia
Description: Biocon Biologics is a global biosimilars company and a subsidiary of Biocon Limited, India’s leading biopharmaceutical enterprise headquartered in Bengaluru. The company focuses on developing, manufacturing, and commercializing affordable and high-quality biosimilars, insulin products, monoclonal antibodies, and other biologic therapies across more than 120 countries. Biocon Biologics has commercialized 10 biosimilars and has a pipeline of 20 biosimilar assets, addressing therapeutic areas like diabetology, oncology, immunology, ophthalmology, bone health, and other non-communicable diseases. Its biosimilars are available globally, including advanced markets such as the United States, Europe, Australia, Canada, and Japan. - Show More
